Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1996
12/19/1996WO1996040739A2 Urethane mediated, gst specific molecular release systems
12/19/1996WO1996040737A1 Reversible cysteine protease inhibitors
12/19/1996WO1996040736A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding
12/19/1996WO1996040729A1 A method of cross-linking amino acid-containing polymers using photoactivatable chemical cross-linkers
12/19/1996WO1996040726A1 Novel carbamate-based cationic lipids
12/19/1996WO1996040723A1 Catalytic dna
12/19/1996WO1996040720A1 Mammalian prostaglandin h synthase-2
12/19/1996WO1996040719A1 Endothelial-monocyte activating polypeptide iii
12/19/1996WO1996040718A1 Expression of lipoproteins
12/19/1996WO1996040715A1 Therapeutic oligonucleotides targeting the human mdr1 and mrp genes
12/19/1996WO1996040714A1 GLYCINE AND PHASEOLUS α-D-GALACTOSIDASES
12/19/1996WO1996040713A1 Cellular apoptosis susceptibility protein (csp) and antisense csp
12/19/1996WO1996040711A1 Cross-linking oligonucleotides
12/19/1996WO1996040710A1 Triplex-forming antisense oligonucleotides having abasic linkers targeting nucleic acids comprising mixed sequences of purines and pyrimidines
12/19/1996WO1996040671A1 Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
12/19/1996WO1996040663A1 Di- and tri-aminoguanidines and their use to inhibit the advanced glycosylation of proteins
12/19/1996WO1996040657A1 Inhibitors of phospholipase a¿2?
12/19/1996WO1996040647A1 α-(1,3-DICARBONYLENOL ETHER) METHYL KETONES AS CYSTEINE PROTEASE INHIBITORS
12/19/1996WO1996040637A1 Stable reagents for the preparation of radiopharmaceuticals
12/19/1996WO1996040633A1 Small molecule inhibitors of rotamase enzyme activity
12/19/1996WO1996040295A1 Monoclonal antibody fragment to human ovarian cancers
12/19/1996WO1996040293A1 Structurally determined metallo-constructs and applications
12/19/1996WO1996040290A1 Immunological combination compositions and methods
12/19/1996WO1996040289A1 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy
12/19/1996WO1996040284A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
12/19/1996WO1996040271A1 Treatment of hemoglobinopathies
12/19/1996WO1996040267A1 The regulation of systemic immune responses utilizing cytokines and antigens
12/19/1996WO1996040266A1 Method of treatment for asthma
12/19/1996WO1996040252A1 High affinity human monoclonal antibodies specific for rsv f-protein
12/19/1996WO1996040251A1 Prevention and treatment of sepsis
12/19/1996WO1996040250A2 Platelet-specific chimeric immunoglobulin and methods of use therefor
12/19/1996WO1996040249A1 Therapeutic uses of ta99
12/19/1996WO1996040248A1 Transvacular and intracellular delivery of lipidized proteins
12/19/1996WO1996040247A1 Methods of increasing cd4+ cell numbers in hiv-infected individuals
12/19/1996WO1996040246A1 Treatment of t cell mediated autoimmune disorders
12/19/1996WO1996040245A1 Improved delivery of diagnostic and therapeutic agents to a target site
12/19/1996WO1996040244A1 Antibodies to porcine cd34 positive cells and uses therefor
12/19/1996WO1996040236A1 Isolated formylated bacterial peptides, nucleic acid molecules and uses thereof
12/19/1996WO1996040232A1 Oral tolerance in skin diseases presenting with t-cell mediated inflammation
12/19/1996WO1996040231A1 Method for obtaining receptor agonist antibodies
12/19/1996WO1996040230A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
12/19/1996WO1996040228A1 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof
12/19/1996WO1996040224A1 Regulation of cytokine synthesis and release
12/19/1996WO1996040223A1 Oxidant scavengers
12/19/1996WO1996040222A1 Hemodilution facilitated by monitoring oxygenation status
12/19/1996WO1996040221A1 Wound healing formulations containing human plasma fibronectin
12/19/1996WO1996040220A1 Treatment of type ii diabetes mellitus with amylin agonists
12/19/1996WO1996040219A1 Inhibin compositions and methods of enhancing production performance
12/19/1996WO1996040218A1 Methods for increasing hematopoietic cells
12/19/1996WO1996040217A1 Thrombopoietin compositions
12/19/1996WO1996040216A1 Reconstituted collagen fiber segment compositions and methods of preparation thereof
12/19/1996WO1996040215A1 Treating immune deficiency diseases using t cell receptor peptides
12/19/1996WO1996040214A1 Novel anti-apoptotic compositions and methods using same
12/19/1996WO1996040213A1 Manufacture and purification of peptides
12/19/1996WO1996040212A1 Retrovirus vectors for expression of cii-ta and activation of hla class ii gene expression and uses thereof
12/19/1996WO1996040211A1 Use of conotoxin peptides u002 and mii for treating or detecting small-cell lung carcinoma
12/19/1996WO1996040210A1 Antibody and antibody fragments for inhibiting the growth of tumors
12/19/1996WO1996040209A1 Method for identifying or isolating a molecule and molecules identified thereby
12/19/1996WO1996040208A1 Novel mu opioid receptor ligands: agonists and antagonists
12/19/1996WO1996040207A1 Novel peptide inhibitors of calmodulin
12/19/1996WO1996040206A1 Novel kappa receptor selective opioid peptides
12/19/1996WO1996040205A1 Metabolic effects of certain glutathione analogs
12/19/1996WO1996040204A1 Novel inhibitors of collagenase-1 and stromelysin-i metalloproteases, pharmaceutical compositions comprising same and methods of their use
12/19/1996WO1996040203A1 Methods of treatment using growth hormone antagonists
12/19/1996WO1996040202A1 Synthesis of n-substituted oligomers
12/19/1996WO1996040200A1 Method for treating tumors with a toxin
12/19/1996WO1996040199A1 Methods of inhibiting phagocytosis
12/19/1996WO1996040198A1 Synthesis of asparagine-linked glycopeptides on a polymeric solid support
12/19/1996WO1996040197A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
12/19/1996WO1996040196A1 Appetite regulating compositions
12/19/1996WO1996040195A1 Gene therapy for myocardial ischemia
12/19/1996WO1996040194A1 Stable formulations of mhc-peptide complexes
12/19/1996WO1996040193A1 CYCLIC ANALOGS OF PTH AND PTHrP
12/19/1996WO1996040192A1 Use of essential oils to increase bioavailability of oral pharmaceutical compounds
12/19/1996WO1996040191A1 The treatment of hiv and other viral infections using combinatory therapy
12/19/1996WO1996040189A1 Peptides and compounds that bind to a receptor
12/19/1996WO1996040188A1 Reducing gelation of a fatty acid-acylated protein
12/19/1996WO1996040186A1 Relaxin-like factor and methods and uses thereof
12/19/1996WO1996040185A1 Relaxin analogs and derivatives methods and uses thereof
12/19/1996WO1996040183A1 OCULAR THERAPY IN SJÖGREN'S SYNDROME USING TOPICALLY APPLIED ANDROGENS OR TGF-$g(b)
12/19/1996WO1996040178A1 Use of co-localized islets and sertoli cells in xenograft cellular transplants
12/19/1996WO1996040174A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
12/19/1996WO1996040173A1 Hapten modified tumor cell extract and methods of treating or screening for cancer
12/19/1996WO1996040164A1 Nucleosides with anti-hepatitis b virus activity
12/19/1996WO1996040162A1 Method of treatment for lung diseases using antisense oligonucleotides
12/19/1996WO1996040159A1 Capped synthetic rna, analogs, and aptamers
12/19/1996WO1996040157A1 USE OF ANTISENSE OLIGONUCLEOTIDES TO IL-6 RECEPTOR mRNA TO INHIBIT CELLULAR PROLIFERATION
12/19/1996WO1996040140A1 Inhibitors of rotamase enzyme activity
12/19/1996WO1996040132A1 Method for inhibiting neoplastic disease in mammals
12/19/1996WO1996040131A1 Method for inhibiting neoplastic disease in mammals
12/19/1996WO1996040118A1 Thrombin inhibitors
12/19/1996WO1996040108A1 Multidentate metal complexes and methods of making and using thereof
12/19/1996WO1996040105A1 Use of gamma-hydroxybutyrate for the stimulation of sleep-related growth hormone secretion
12/19/1996WO1996040104A1 Hydroxyl ions as unique therapeutic agents and compounds that modulate ions, compounds
12/19/1996WO1996040095A1 Method for treating multiple sclerosis
12/19/1996WO1996040084A1 Compositions and methods for use of pressure sensitive adhesive transdermal devices containing a bioadhesive humectant
12/19/1996WO1996040082A2 Apparatus and method for delivering a biologically active compound into a biological environment
12/19/1996WO1996040078A1 Delivery of drugs to the lower gi tract
12/19/1996WO1996040074A2 Device for releasing aggregation-stabilized, biologically active agent
12/19/1996WO1996040073A2 Composition for sustained release of non-aggregated erythropoietin
1 ... 2745 2746 2747 2748 2749 2750 2751 2752 2753 2754 2755 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 ... 3163